Position in ABVX
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$902,703
+$803,491 QoQ
Shares Held
6,774
+660.3% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#171
of 302 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABVX Over Time
Shares Held
Position Value (USD)
Derivatives in ABVX
reported options exposure · as of Jun 30, 2026CallValue
$1
CallShares
35
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026Covestor Ltd holds $4,614,813 across 168 Biotechnology names. ABVX ranks #1 (19.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABVX |
Abivax S.A.
This page
|
6,774 | $902,703 | |
| 2 | PRTA |
Prothena Corp Public Ltd Co
|
25,190 | $246,610 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
1,528 | $187,302 | |
| 4 | INCY |
Incyte Corp
|
1,629 | $184,663 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
493 | $183,233 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
368 | $182,796 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
936 | $175,294 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
2,093 | $155,886 |
All Filings in ABVX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $902,703 | 6,774 | Shares | Sole | 2026-08-07 | |
| 2026-06-30 | $1 | 35 | Call | Sole | 2026-08-07 | |
| 2026-03-31 | $99,212 | 891 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $131,348 | 974 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $96,446 | 1,136 | Shares | Sole | 2025-10-30 | |
| 2025-03-31 | $16,625 | 2,660 | Shares | Sole | 2025-05-12 | |
| No filing history on record for this holder in this stock. | ||||||